Ipilimumab for Melanoma discussion with Dr. Jeffrey Weber
Author: onclivetv
Added: 02/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 25, 2015 Category: Cancer & Oncology Source Type: podcasts
Combining Nivolumab and Ipilimumab for the Treatment of Advanced Melanoma discussion with Dr. Sznol
A phase I trial that examined the combination of nivolumab and ipilimumab for the treatment of advanced melanoma. The data presented at the 2014 ASCO Annual Meeting was an updated survival and clinica...
Author: onclivetv
Added: 02/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 25, 2015 Category: Cancer & Oncology Source Type: podcasts
Dr. Wolchok discusses Ipilimumab After Complete Resection of Stage III Melanoma
The initial efficacy and safety results from the EORTC 18071 phase III trial, which looked at ipilimumab versus placebo after complete resection of stage III melanoma.
Jedd D. Wolchok, MD, PhD, medic...
Author: onclivetv
Added: 02/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 25, 2015 Category: Cancer & Oncology Source Type: podcasts
Phase I Trial of Concurrent Nivolumab and Ipilimumab for Advanced Melanoma discussion with Dr. Kluger
The results from a phase I trial of nivolumab and ipilimumab for the treatment of patients with advanced melanoma.
Harriet Kluger, MD, associate professor of medicine, Yale Cancer Center,
More fro...
Author: onclivetv
Added: 02/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 25, 2015 Category: Cancer & Oncology Source Type: podcasts
Dr. Kluger on Toxicity of Nivolumab/ Ipilimumab for Advanced Melanoma
Toxicity of Nivolumab/ Ipilimumab for Advanced Melanoma
Author: onclivetv
Added: 02/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 25, 2015 Category: Cancer & Oncology Source Type: podcasts
Melanoma Immunotherapy, Pt. 1: The End of the Beginning
http://cancerGRACE.org/...
Immunotherapy Forum Video #16: In Part 1 of 2 videos on this topic, Dr. Jedd Wolchok provides a history of one of the first immunotherapy drugs, Yervoy (ipilumumab), and the...
Author: cancergrace
Added: 02/05/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 5, 2015 Category: Cancer & Oncology Source Type: podcasts
Dr Hans Hammers discusses the Phase 1 clinical trial of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC)
At the Thirteenth International Kidney Cancer Symposium, Dr Hans Hammers (Johns Hopkins, MD) discusses the Phase 1 clinical trial that studied the immune checkpoint inhibitors, nivolumab and ipilimuma...
Author: EMJ
Added: 11/25/2014 (Source: Oncology Tube)
Source: Oncology Tube - November 25, 2014 Category: Cancer & Oncology Source Type: podcasts
Dr. Robert Andtbacka Discusses T-VEC Plus Ipilimumab in Unresected Melanoma
Robert H. I. Andtbacka, MD, CM, a surgeon and investigator with Intermountain Healthcare and Huntsman Cancer Institute, discusses the safety and efficacy of talimogene laherparepvec (T-VEC) in combina...
Author: onclivetv
Added: 09/10/2014 (Source: Oncology Tube)
Source: Oncology Tube - September 10, 2014 Category: Cancer & Oncology Source Type: podcasts
Interview Dr. Sznol, ASCO 2014
Dr. Mario Sznol discusses the results of an expanded phase I study combining ipilimumab and nivolumab in patients with advanced melanoma. The combination immunotherapy resulted in an unprecedented med...
Author: feeds
Added: 06/02/2014 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2014 Category: Cancer & Oncology Source Type: podcasts
Ipilimumab Goes the Distance in Melanoma Survival
Drs. Antoni Ribas and Caroline Robert discuss hallmark melanoma findings in targeted therapies, immunotherapy, and combination therapies presented at ECC 2013. (Source: Medscape Oncology)
Source: Medscape Oncology - October 8, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Ipilimumab Goes the Distance in Melanoma Survival
Drs. Antoni Ribas and Caroline Robert discuss hallmark melanoma findings in targeted therapies, immunotherapy, and combination therapies presented at ECC 2013. (Source: Medscape Dermatology Podcast)
Source: Medscape Dermatology Podcast - October 8, 2013 Category: Dermatology Authors: Medscape Source Type: podcasts
ASCO 2013 - Phase I/II trial of PD-1 antibody nivolumab with peptide vaccine in patients naive to or that failed ipilimumab - Dr. Jeffrey Weber
Video interview with Dr. Jeffrey Weber Speaking on Phase I/II trial of PD-1 antibody nivolumab with peptide vaccine in patients naive to or that failed ipilimumab at ASCO 2013.
Author: oncologyeducation
Added: 06/23/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 23, 2013 Category: Cancer & Oncology Source Type: podcasts
GRACEcast-103_Lung-Cancer_Immunotherapy: Yervoy, anti-PD-1, Reolysin, Talactoferrin by Dr. Brahmer
http://cancerGRACE.org/...
Dr. Julie Brahmer reviews science and early trial results for immunotherapies for lung cancer ranging from cancer vaccines to anti-cancer viruses.
Author: cancergrace
Added: 01/16/2013 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2013 Category: Cancer & Oncology Source Type: podcasts
Melanoma: Ipilimumab Improves Survival in Patients With Metastatic Melanoma
Dr. Jeffrey Weber highlights the important findings in melanoma presented at ASCO 2010, focusing on a breakthrough study of ipilimumab in patients with stage 3 or 4 metastatic melanoma. (Source: Medscape Dermatology Podcast)
Source: Medscape Dermatology Podcast - June 15, 2010 Category: Dermatology Authors: Medscape Source Type: podcasts
